Indeed, IGF-1 levels were found significantly decreased in patients with autism compared to healthy controls (Riikonen et al., 2006) and IGF-1 treatment has shown beneficial effects in animal studies and was introduced as an experimental treatment for ASD (Canitano, 2014). The gene discussed is IGF1; the disease is autism.